Skip to main content
letter
. 2020 Jun 21;81(3):e72–e74. doi: 10.1016/j.jinf.2020.06.043

Fig. 1.

Fig 1

(A) Incidence of hepatic complications in COVID-19 patients; (B) Incidence of acute hepatic injury in COVID-19 patients, by clinically relevant characteristics

AHI, acute hepatic injury; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval (bars); CLD, chronic liver disease; *, p-value for meta-regression.